Skip to main content

Table 5 Primary and secondary outcomes at baseline and the completion of study. Within-group analysis was performed

From: A randomized controlled pilot trial to assess the effectiveness of a specially formulated food supplement and pelvic floor muscle training in women with stress-predominant urinary incontinence

 

Control Group at Baseline (N = 16)

Control Group at 6 weeks (N = 16)

P-value

Treatment Group at Baseline (N = 16)

Treatment Group at 6 weeks (N = 16)

P-value

UDI-6 score (mean ± SD)

43 ± 18

33 ± 26

0.22

45 ± 21

29 ± 21

0.02

IIQ-7 score before (mean ± SD)

48 ± 23

40 ± 28

0.36

50 ± 30

30 ± 21

0.01

Maximum vaginal squeeze pressure (cmH2O, mean ± SD)

36 ± 18

41 ± 21

0.13

30 ± 15

45 ± 28

0.001

Oxford Scale (mean ± SD)

2.4 ± 0.8

2.9 ± 0.5

0.01

2.2 ± 0.6

2.8 ± 0.5

0.0005

PGI-S score (mean ± SD)

2.8 ± 0.8

2.6 ± 0.8

0.45

3.1 ± 0.8

2.3 ± 0.8

0.0001

  1. Urogenital Distress Inventory (UDI-6), Incontinence Impact Questionnaire (IIQ-7), Patient Global Impression of Severity (PGI-S)
Back to article page

BMC Women's Health

ISSN: 1472-6874

Contact us